# Fujirebio acquires ADx NeuroSciences for EUR 40 million

Fujirebio, a subsidiary of H.U. Group Holdings, acquired ADx NeuroSciences NV for 40 million euros. ADx NeuroSciences becomes a wholly owned subsidiary of Fujirebio Europe NV. The deal is expected to close in July 2022.

- Type: Acquisition
- Announced: 2022-06-23
- Where: Gent, Belgium
- Value: $42.0M (40.0M EUR)
- Status: announced
- Products: diagnostic antibodies and assays for neurodegenerative diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fujirebio Holdings](https://endata.com/companies/63654.md) (acquirer)
- [ADx NeuroSciences](https://endata.com/companies/63655.md) (target)
- [H.U. Group Holdings](https://endata.com/companies/63656.md) (partner)

## Sources

- [fujirebio.com](https://www.fujirebio.com/en/news-events/fujirebio-acquires-adx-neurosciences-and-confirms-its-intentions-to-bring-better-and), 2022-06-23: "Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.